Protein S abnormalities: A diagnostic nightmare

American Journal of Hematology

Volumn 86, Issue 5, 2011, Pages 418-421

  Marlar, Richard A ^a,b   Gausman, Jana N ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S;

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN S DEFICIENCY; RELIABILITY; REPRODUCIBILITY; RISK FACTOR; THROMBOSIS;

DECISION TREES; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROTEIN S; PROTEIN S DEFICIENCY;

EID: 79955132630     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21992     Document Type: Article

References (24)

1. Dahlback B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett 2005; 579: 3310-3316.
2. Garcia de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost 2007; 98: 543-556.
3. ten Kate MK, van deer Meer J. Protein S deficiency: A clinical perspective. Haemophilia 2008; 14: 1222-1228.
4. Dahlback B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost 2007; 98: 90-96.
5. Castoldi E.Hackeng TM. Regulation of coagulation by protein S. Curr Opin Hemat 2008; 15: 529-536.
6. Lijfering WM, Mulder R, ten Kate MK, Veeger NJ, Mulder AB, van der Meer J. Clinical relevance of decreased free protein S levels: Results from a retrospective family cohort study involving 1143 relatives. Blood 2009; 113: 1225-1230.
7. Van Cott EM, Ledford-Kraemer M, Meijer P, Nichols WL, Johnson SM, Peerschke EI. Protein S assays: An analysis of North American Specialized Coagulation Laboratory Association proficiency testing. Am J Clin Path 2005; 123: 778-785.
8. ten Kate MK, Platteel M, Mulder R, Terpstra P, Nicolaes GA, Reitsma PH, van der Steege G, van der Meer J. PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations. Hum Mutat 2008; 29: 939-947.
9. Johnston AM, Aboud M, Morel-Kopp MC, Coyle L, Ward CM. Use of a functional assay to diagnose protein S deficiency; inappropriate testing yields equivocal results. Intern Med J 2007; 37: 409-411.
10. Marlar RA, Potts RM, Welsh CW. Accuracy of diagnosis of protein S deficiency by protein S activity and antigen assays. J Clin Ligand 2005; 28: 130-135.
11. Anonymous. Inherited thrombophilia: Memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting. Bull WHO 1997; 75: 177-189.
12. Zurcher M, Sulzer I, Barizzi G, Lammle B, Alberio L. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 2008; 99: 416-426.
13. Rodger MA, Carrier M, Gervais M, Rock G. Normal functional protein S activity does not exclude protein S deficiency. Pathophysio Haemost Thromb 2003; 33: 202-205.
14. Favaloro EJ, Bonar R. Emerging technologies and quality assurance in hemostasis: A review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program. Sem Thromb Hemost 2007; 33: 235-242.
15. Meijer P, Haverkate F, Kluft C. Performance goals for the laboratory testing of antithrombin, protein C and protein S. Thromb Haemost 2006; 96: 584-589.
16. Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemostas 2010; 103: 718-727.
17. Munster AM, Sidelmann JJ, Gram J. Thrombophilia screening in the acute phase of deep venous thrombosis. Scand J Clin Lab Invest 2009; 69: 633-635.
18. Dykes AC, Walker ID, McMahon AD, Islam SIAM, Tait RC. A study of protein S antigen levels in 3788 healthy volunteers: Influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-641.
19. Henkens CM, Bom VJ, van der Schaaf W, Pelsma PM, Sibinga CT, de Kam PJ, van der Meer J. Plasma levels of protein S, protein C, and factor X: Effects of sex, hormonal state and age. Thromb Haemost 1995; 74: 1271-1275.
20. Norris LA, Brosnan J, Bonnar J, Conard J, Kluft C, Hellgren M. Inhibitors and activation markers of the haemostatic system during hormone therapy: A comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone. Thromb Haemost 2008; 100: 253-260.
21. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172.
22. Marlar RA, Fink L, Miller J. Laboratory approach to thrombotic risk. In: McPherson RA, Pincus MR, editors. Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed. New York; Saunders; 2006. pp 770-777.
23. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiological considerations for protein S assays. Arch Pathol Lab Med 2002; 126: 1349-1366.
24. Khor B, Van Cott EM. Laboratory evaluation of Hypercoagulability. Clin Lab Med 2009; 29: 339-366.